Genetics in the Pathogenesis of Esophageal Cancer: Possible Predictive and Prognostic Factors
- 1 February 2010
- journal article
- Published by Elsevier BV in Journal of Gastrointestinal Surgery
- Vol. 14 (1), S75-S80
- https://doi.org/10.1007/s11605-009-1021-5
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Cyclooxygenase-2 expression is related to prognosis in patients with esophageal squamous cell carcinomaEuropean Journal of Surgical Oncology, 2008
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- High Cyclooxygenase-2 Expression Following Neoadjuvant Radiochemotherapy Is Associated with Minor Histopathologic Response and Poor Prognosis in Esophageal CancerClinical Cancer Research, 2005
- Neoadjuvant chemoradiotherapy for esophageal carcinoma: A meta-analysisSurgery, 2005
- Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trialEuropean Journal of Surgical Oncology, 2004
- Prognostic Significance of Stromelysin-3 and Tissue Inhibitor of Matrix Metalloproteinase-2 in Esophageal CancerOncology, 2004
- Vascular endothelial growth factor in esophageal cancerJournal of Surgical Oncology, 2004
- The Hallmarks of CancerCell, 2000
- p53, p21(Waf1/Cip1) and cyclin D1 protein expression and prognosis in esophageal cancerDiseases of the Esophagus, 1999
- Prognostic Value of Laurén Classification and c-erbB-2 Oncogene Overexpression in Adenocarcinoma of the Esophagus and Gastroesophageal JunctionAnnals of Surgical Oncology, 1999